e-learning
resources
Berlin 2008
Monday, 06.10.2008
New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Performance of quantiferon test in screening for latent tuberculous infection in rheumatoid arthritis patients undergoing anti-TNF therapy
D. Boisteanu, C. Ancuta, R. Chirieac, C. Tacu, E. Ancuta, R. Vasiluta, R. Miron, C. Archip (Iasi, Romania)
Source:
Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Session:
New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Session type:
E-Communication Session
Number:
2844
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Boisteanu, C. Ancuta, R. Chirieac, C. Tacu, E. Ancuta, R. Vasiluta, R. Miron, C. Archip (Iasi, Romania). Performance of quantiferon test in screening for latent tuberculous infection in rheumatoid arthritis patients undergoing anti-TNF therapy. Eur Respir J 2008; 32: Suppl. 52, 2844
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Comparison between tuberculin skin testing and QuantiFERON Gold-In Tube for detection of latent tuberculosis in rheumatoid arthritis patients in a TB endemic population
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Latent tuberculosis in patients with rheumatoid arthritis. Evaluating cellular response and new diagnostic strategies
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
QuantiFERON-TB GOLD vs. TST methods of detection tuberculosis infection in rheumatoid arthritis patients with previously TNF α inhibitors treatment
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
Screening and monitoring of TB infection in rheumatological patients on biologics therapy
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
The role of immunological tests in the diagnosis of tuberculosis infection in children with juvenile idiopathic arthritis (JIA)
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018
Pulmonary non-Hodgkin‘s lymphoma developed during long-term methotrexate therapy for rheumatoid arthritis
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Comparison of LTBI screening strategies before TNF inhibitor treatment in inflammatory arthritis
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Comparison of Quanti-FERON-TB Gold and tuberculin skin test for diagnosis of latent tuberculosis infection in patients with chronic schizophrenia
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Anti-TNF-alpha therapy in patients with latent tuberculosis incidence
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease
Source: Eur Respir J 2006; 28: Suppl. 50, 131s
Year: 2006
Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Outcome results of antituberculous treatment in latent or manifest tuberculosis patients featuring granulomatous uveitis
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Outcome results of antituberculous treatment in latent or manifest tuberculosis patients featuring granulomatous uveitis
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010
Value of QFT-IT test for diagnosing latent TB infection in HIV+
Source: ISSN=ISSN 1810-6838, ISBN=, page=284
Year: 2007
Modulation of whole-blood IGRA response in patients with latent TB infection during treatment
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Our approach about latent tuberculosis infection in patients who are given anti-TNF alpha therapy
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Performance and post-treatment conversion of latent tuberculosis test (QUANTIFERON) in immunocompromised patients with neoplasmatic disease
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Clinical evaluation of QuantiFERON TB -2g test in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis
Source: Eur Respir J 2004; 24 : 708
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept